初诊多发性骨髓瘤的临床试验
总计3475个结果
-
Northwestern UniversityNational Cancer Institute (NCI)完全的
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)终止
-
Zhejiang UniversityYake Biotechnology Ltd.招聘中
-
National University Hospital, SingaporeCelgene; International Myeloma Foundation未知
-
Regeneron Pharmaceuticals尚未招聘意义未明的单克隆丙种球蛋白病 (MGUS) | 冒烟型多发性骨髓瘤 (SMM)
-
Fujian Medical University Union HospitalThe Affiliated Hospital Of Guizhou Medical University; The Second Hospital of Anhui Medical... 和其他合作者招聘中
-
M.D. Anderson Cancer Center招聘中
-
Oxford University Hospitals NHS TrustAmgen完全的
-
The Second Affiliated Hospital of Kunming Medical...尚未招聘急性髓性白血病 | 地西他滨 | 维奈托克 | 老年急性髓性白血病患者 | 不合格、新诊断 AML中国
-
Wuhan General Hospital of Guangzhou Military Command完全的
-
Alliance Foundation Trials, LLC.Takeda; Janssen Scientific Affairs, LLC; Celgene Corporation主动,不招人
-
Shahid Beheshti University of Medical Sciences尚未招聘
-
Shenzhen Geno-Immune Medical InstituteThe Second Affiliated Hospital of Hainan Medical University招聘中
-
University of ChicagoGlaxoSmithKline; Amgen招聘中
-
Sheba Medical Center招聘中
-
Chunrui LiNanjing IASO Biotherapeutics Co.,Ltd招聘中
-
Xinqiao Hospital of ChongqingSichuan Kelun-Biotech Biopharmaceutical Co., Ltd.招聘中
-
University of Colorado, DenverNational Cancer Institute (NCI); Karyopharm Therapeutics Inc招聘中
-
Karyopharm Therapeutics Inc招聘中
-
Oslo University Hospital招聘中
-
Travera IncMassachusetts General Hospital; Dana-Farber Cancer Institute; Weill Medical College of Cornell... 和其他合作者招聘中
-
Ichnos Sciences SAGlenmark Pharmaceuticals S.A.完全的
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Millennium Pharmaceuticals, Inc.; Celgene Corporation主动,不招人
-
AbbVie完全的多发性骨髓瘤 (MM)美国, 阿根廷, 澳大利亚, 巴西, 加拿大, 克罗地亚, 捷克语, 法国, 德国, 希腊, 爱尔兰, 以色列, 意大利, 荷兰, 挪威, 波兰, 罗马尼亚, 沙特阿拉伯, 斯洛文尼亚, 西班牙, 台湾, 火鸡
-
Amgen终止
-
Raija SilvennoinenBristol-Myers Squibb; Amgen; Hospital District of Helsinki and Uusimaa完全的
-
Precision BioSciences, Inc.终止
-
Allogene Therapeutics主动,不招人
-
iOMEDICO AGAmgen主动,不招人